PRIMARY CARE
Recommendation 1
Ocretoride (somatostatin analog), bromocriptine and cabergoline (dopamine agonist), pegvisomat (GH antagonist)
Recommendation 1
Detailed patient history, a thorough clinical evaluation, identification of characteristic findingsRecommendation 2
elevated levels of growth hormone or IGF-1 (insulin growth factor) .Recommendation 1
Detailed patient history, a thorough clinical evaluation, identification of characteristic findingsRecommendation 2
elevated levels of growth hormone or IGF-1 (insulin growth factor) .Recommendation 1
Transsphenoidal surgery for pituitary removalRecommendation 1
Ocretoride (somatostatin analog), bromocriptine and cabergoline (dopamine agonist), pegvisomat (GH antagonist)Recommendation 1
~ 3000 physicians . Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health.Recommendation 1
13 actively recruitingFollow to receive regular updates to the latest research development on this disease via email newsletter.